Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (251-260 of 314) with videos related to

Pageof 32
Sort By:
Lancet (London, England)|August 16, 2015
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialMiklos Pless, Roger Stupp, Hans-Beat Ris, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Molecular Cell|February 4, 2021
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cellsTianzhi Huang, Yongyong Yang, Xiao Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastomaAnastasia Murat, Eugenia Migliavacca, Thierry Gorlia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
Acta Neuropathologica Communications|December 30, 2025
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomasDrew Duckett, Lucas Santana-Santos, Matthew McCord, et al.
Brain : a Journal of Neurology|March 30, 2016
Corticosteroids compromise survival in glioblastomaKenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
Cancer Cell|December 13, 2017
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in GlioblastomaTianzhi Huang, Chung Kwon Kim, Angel A Alvarez, et al.
Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.
Pageof 32

Showing results (251-260 of 314) with videos related to

Sort By:
Pageof 32
Lancet (London, England)|August 16, 2015
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialMiklos Pless, Roger Stupp, Hans-Beat Ris, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Molecular Cell|February 4, 2021
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cellsTianzhi Huang, Yongyong Yang, Xiao Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastomaAnastasia Murat, Eugenia Migliavacca, Thierry Gorlia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
Acta Neuropathologica Communications|December 30, 2025
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomasDrew Duckett, Lucas Santana-Santos, Matthew McCord, et al.
Brain : a Journal of Neurology|March 30, 2016
Corticosteroids compromise survival in glioblastomaKenneth L Pitter, Ilaria Tamagno, Kristina Alikhanyan, et al.
Cancer Cell|December 13, 2017
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in GlioblastomaTianzhi Huang, Chung Kwon Kim, Angel A Alvarez, et al.
Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.
Pageof 32